• Affiliate Professor, Global Health
Michael Chung

325 Ninth Avenue
Box 359909
Seattle, WA 98104
United States

Phone Number: 
Select from the following:

Dr. Chung lives in Nairobi, Kenya and has been involved in HIV treatment, epidemiology research, and medical education in Kenya and Vietnam since 2002. He has led randomized clinical trials on adherence to antiretroviral medications, cervical cancer screening and treatment, and transmitted antiretroviral drug resistance. In 2004, Dr. Chung co-founded the Coptic Hope Center for Infectious Diseases, an HIV clinic which has become one of the largest single-site antiretroviral treatment centers in Kenya. He is the Director of Treatment, Research, and Expert Education (TREE), a program dedicated to addressing the health needs of people living in resource-limited settings. Dr. Chung leads a UW partnership with the University of Nairobi to train fellows to manage the Kenyan HIV epidemic and to give health researchers more skills in information and communication technology (ICT). As co-director of the Department of Global Health’s E-learning Initiative (eDGH), he has pioneered the use of the internet to deliver UW academic courses to an international audience, building upon the principle that better medical education leads to better patient care. Dr. Chung co-directs the Mekong Health Collaborative which seeks to leverage UW academic resources to improve health in Vietnam, Laos, and Cambodia.

  • MD (University of Chicago)
  • MPH (Harvard University)
  • BA (Oberlin College)
Country Affiliations 
Health Topics 
  • Cervical Cancer
  • Cost-Effectiveness
  • Disease Surveillance
  • Distance Learning
  • Education and Training
  • Epidemiology
  • Health Economics
  • HPV
  • Implementation Science
  • Infectious Diseases
  • Infectious Diseases (other than STDs)
  • Non-Communicable Diseases
  • Operations Research
  • Pulmonary Diseases and Pneumonia
  • Research
  • STDs (other than HIV)
  • Telemedicine

Chung MH, McKenzie KP, De Vuyst H, Richardson BA, Rana F, Pamnani R, Njoroge JW, Nyongesa-Malava E, Sakr SR, John-Stewart GC, Mugo NR. Comparing Papanicolau smear, visual inspection with acetic acid and human papillomavirus cervical cancer screening methods among HIV-positive women by immune status and antiretroviral therapy. AIDS. 2013 Nov 28; 27(18):2909-19. PubMed PMID: 23842133; PubMed Central PMCID: PMC4007364

Chung MH, Beck IA, Dross S, Tapia K, Kiarie JN, Richardson BA, Overbaugh J, Sakr SR, John-Stewart GC, Frenkel LM. Oligonucleotide ligation assay detects HIV drug resistance associated with virologic failure among antiretroviral-naive adults in Kenya. J Acquir Immune Defic Syndr. 2014 Nov 1;67(3):246-53. PubMed PMID: 25140907; PubMed Central PMCID: PMC4197120.

Chung MH, Richardson BA, Tapia K, Benki-Nugent S, Kiarie JN, Simoni JM, Overbaugh J, Attwa M, John-Stewart GC. A randomized controlled trial comparing the effects of counseling and alarm device on HAART adherence and virologic outcomes. PLoS Med. 2011 Mar;8(3):e1000422. PubMed PMID: 21390262; PubMed Central PMCID: PMC3046986.

Lester RT, Ritvo P, Mills EJ, Kariri A, Karanja S, Chung MH, Jack W, Habyarimana J, Sadatsafavi M, Najafzadeh M, Marra CA, Estambale B, Ngugi E, Ball TB, Thabane L, Gelmon LJ, Kimani J, Ackers M, Plummer FA. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet. 2010 Nov 27;376(9755):1838-45. PubMed PMID: 21071074.

Chung MH, Kiarie JN, Richardson BA, Lehman DA, Overbaugh J, Kinuthia J, Njiri F, John-Stewart GC. (2008). Highly Active Antiretroviral Therapy versus Zidovudine/Nevirapine Effects on Breastmilk HIV-1 RNA: A Phase II Randomized Clinical Trial. Antiviral Therapy. 2008;13(6):799-807. PubMed PMID: 18839781; NIHMSID: NIHMS189689; PubMed Central PMCID: PMC2859833.